216 related articles for article (PubMed ID: 29419347)
21. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
Bai Y; Yang J; Liu J; Ning H; Zhang R
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
[TBL] [Abstract][Full Text] [Related]
22. [Primary Sjögren's syndrome with pulmonary hypertension].
Usui K; Anzai C; Sano K; Kumazaki S; Ishihara T
Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):478-81. PubMed ID: 9742868
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
[No Abstract] [Full Text] [Related]
24. Cerebellar involvement in patients withprimary Sjögren's syndrome: diagnosis and treatment.
Yang H; Sun Y; Zhao L; Zhang X; Zhang F
Clin Rheumatol; 2018 May; 37(5):1207-1213. PubMed ID: 29380161
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for progression and prognosis of primary Sjögren's syndrome-associated interstitial lung disease in a Chinese population.
Xu Y; Zhou J; Dong X; Guo X; Lu Y; Zheng Y
Int J Rheum Dis; 2020 Dec; 23(12):1734-1740. PubMed ID: 33226736
[TBL] [Abstract][Full Text] [Related]
26. Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.
Ngian GS; Stevens W; Prior D; Gabbay E; Roddy J; Tran A; Minson R; Hill C; Chow K; Sahhar J; Proudman S; Nikpour M
Arthritis Res Ther; 2012 Oct; 14(5):R213. PubMed ID: 23039366
[TBL] [Abstract][Full Text] [Related]
27. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
28. Primary Sjögren's Syndrome with two extraglandular sites involvement - case report.
Szturmowicz M; Wilińska E; Paczek A; Wawrzyńska L; Opoka L; Gątarek J; Langfort R; Rowińska-Zakrzewska E; Torbicki A
Pneumonol Alergol Pol; 2010; 78(6):445-50. PubMed ID: 21077037
[TBL] [Abstract][Full Text] [Related]
29. Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren's syndrome following immunosuppressive therapy.
Naniwa T; Takeda Y
Mod Rheumatol; 2011 Dec; 21(6):637-40. PubMed ID: 21394665
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of coronary heart disease among patients with primary Sjögren's syndrome: a nationwide population-based cohort study.
Wu XF; Huang JY; Chiou JY; Chen HH; Wei JC; Dong LL
Sci Rep; 2018 Feb; 8(1):2209. PubMed ID: 29396489
[TBL] [Abstract][Full Text] [Related]
31. Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.
Huang C; Li M; Liu Y; Wang Q; Guo X; Zhao J; Lai J; Tian Z; Zhao Y; Zeng X
Medicine (Baltimore); 2016 Mar; 95(10):e2761. PubMed ID: 26962774
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
Lin CY; Ko CH; Hsu CY; Chen HA
Semin Arthritis Rheum; 2020 Oct; 50(5):957-962. PubMed ID: 32906031
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.
Sato T; Hatano M; Iwasaki Y; Maki H; Saito A; Minatsuki S; Inaba T; Amiya E; Fujio K; Watanabe M; Yamamoto K; Komuro I
PLoS One; 2018; 13(5):e0197297. PubMed ID: 29763424
[TBL] [Abstract][Full Text] [Related]
34. Interstitial lung disease in Sjögren's syndrome: a clinical review.
Luppi F; Sebastiani M; Silva M; Sverzellati N; Cavazza A; Salvarani C; Manfredi A
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):291-300. PubMed ID: 33095142
[TBL] [Abstract][Full Text] [Related]
35. Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome.
Kaufman I; Schwartz D; Caspi D; Paran D
Scand J Rheumatol; 2008; 37(3):213-8. PubMed ID: 18465457
[TBL] [Abstract][Full Text] [Related]
36. Withdrawal of epoprostenol therapy in a patient with pulmonary hypertension associated with Sjögren's syndrome.
Fujita T; Tanabe N; Kasahara Y; Sugiura T; Sakao S; Tatsumi K
Intern Med; 2014; 53(19):2237-40. PubMed ID: 25274237
[TBL] [Abstract][Full Text] [Related]
37. Interstitial lung disease in primary Sjögren's syndrome.
Roca F; Dominique S; Schmidt J; Smail A; Duhaut P; Lévesque H; Marie I
Autoimmun Rev; 2017 Jan; 16(1):48-54. PubMed ID: 27682894
[TBL] [Abstract][Full Text] [Related]
38. A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndrome.
Kyono M; Okamoto M; Sakamoto S; Iwanaga T; Momosaki S; Takeoka H; Toyama T; Naitou-Nishida Y; Nouno T; Yamada H; Yano R; Miyamura T; Hoshino T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):248-252. PubMed ID: 33086997
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary manifestations of Sjögren's syndrome.
Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
[TBL] [Abstract][Full Text] [Related]
40. Combined disease with pulmonary arterial hypertension and pulmonary venous hypertension revealed after treatment of heart failure with preserved ejection fraction in a case with primary Sjögren syndrome.
Yamasaki Y; Suzuki K; Kamijima R; Asari Y; Tsuchida K; Mizushima M; Okazaki T; Akashi YJ; Ozaki S; Yamada H
Mod Rheumatol; 2018 Jan; 28(1):193-196. PubMed ID: 26052802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
